Gender Pay Gap Report

New legislation came into force in the UK on 5 April 2017 requiring companies with more than 250 employees to publish data about their gender pay gap into the public realm. The legislation was introduced as part of the UK government’s commitment to ensure that women have the same opportunities as men to fulfil their potential in the workplace. The government’s stated aim is to completely eliminate the gender pay gap over time.

As of 4 April 2018. Abcam’s mean gender pay gap was 14.2% whilst our median gender pay gap was 11.1%. Our mean and median bonus gap was 45.6% and 12.8% respectively. We are dedicated to addressing our gender pay gap.  We are approaching this ambition boldly with the introduction of new programmes, complementing existing initiatives that have shown promise to date.  Listed below are the seven commitments we have made to help us address our gender pay gap:

  1. We will agree and introduce targets for female representation in senior leadership roles;
  2. We will ensure that there is at least 1 woman on every senior shortlist;
  3. We will conduct a survey of colleagues who have taken maternity/paternity leave to understand what went well and what could be better. From this action recommendations on how we can better support returners through a return to work programme will be made;
  4. We will review the terms of our maternity and paternity policies;
  5. We will Introduce unconscious bias training for line managers involved in recruitment and promotion decisions;
  6. We will review the terms of our part time and flexible working policies; and
  7. We will introduce development networks for women and for families.

We believe that taking the actions as described above will stimulate meaningful and necessary change.

Please click here to access Abcam’s 2018 Gender Pay Gap Report.


About Abcam

Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

Read more +

Abcam Products

As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

Read more +

Investor Information

Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

Read more +

Abcam News

We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

Read more +